About [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone
[4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone (PubChem CID 129261425) has the molecular formula C29H33ClN8O
and a molecular weight of 545.09 g/mol. Its IUPAC name is [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone.
Molecular Properties
| Compound Name | [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone |
| PubChem CID | 129261425 |
| Molecular Formula | C29H33ClN8O |
| Molecular Weight | 545.09 g/mol |
| Exact Mass | 544.25 |
| IUPAC Name | [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone |
| SMILES | CC(c1ccnc(Nc2nc3c(Cl)c(-c4cnn(CC5CC5)c4)ccc3[nH]2)c1)N1CCN(C(=O)C2CC2)CC1 |
| InChI | InChI=1S/C29H33ClN8O/c1-18(36-10-12-37(13-11-36)28(39)20-4-5-20)21-8-9-31-25(14-21)34-29-33-24-7-6-23(26(30)27(24)35-29)22-15-32-38(17-22)16-19-2-3-19/h6-9,14-15,17-20H,2-5,10-13,16H2,1H3,(H2,31,33,34,35) |
| InChIKey | RQWMKVXVOISHFU-UHFFFAOYSA-N |
| XLogP | 5.24 |
| TPSA | 94.97 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 545.09 |
| LogP ≤ 5 | 5.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone?
The IUPAC name of [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone (CID 129261425) is [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone.
What is the SMILES notation for [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone?
The canonical SMILES for [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone is CC(c1ccnc(Nc2nc3c(Cl)c(-c4cnn(CC5CC5)c4)ccc3[nH]2)c1)N1CCN(C(=O)C2CC2)CC1.
What is the InChIKey of [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone?
The InChIKey is RQWMKVXVOISHFU-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H33ClN8O/c1-18(36-10-12-37(13-11-36)28(39)20-4-5-20)21-8-9-31-25(14-21)34-29-33-24-7-6-23(26(30)27(24)35-29)22-15-32-38(17-22)16-19-2-3-19/h6-9,14-15,17-20H,2-5,10-13,16H2,1H3,(H2,31,33,34,35).
What are the key properties of [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone?
[4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone has a molecular weight of 545.09 g/mol, XLogP of 5.24, 8 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[1-[2-[[4-chloro-5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazin-1-yl]-cyclopropylmethanone is sourced from PubChem (CID 129261425), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).